It's a run-of-the-mill 97% gain for shares of Transcept Pharmaceuticals (TSPT) following...
It's a run-of-the-mill 97% gain for shares of Transcept Pharmaceuticals (TSPT) following yesterday's announcement the FDA was "generally" on board with its Intermezzo drug. Even with the blockbuster day, shares of the micro-cap are still off 11% for the year.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs